Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

A novel human cancer culture model for the study of prostate cancer

Oncogene volume 20, pages 8036–8041 (2001)Cite this article

Abstract

Research into molecular and genetic mechanisms underlying prostate carcinogenesis would be greatly advanced by in vitro models of prostate tumors representing primary tumors. We have successfully established an immortalized human prostate epithelial (HPE) cell culture derived from a primary tumor with telomerase. The actively proliferating early passaged RC-58T cells were transduced through infection with a retrovirus vector expressing the human telomerase catalytic subunit (hTERT). A high level of telomerase was detected in RC-58T/hTERT cells but not RC-58T cells. RC-58T/hTERT cells are currently growing well at passage 50, whereas RC-58T cells senesced at passage 7. RC-58T/hTERT cells exhibit transformed morphology. More importantly, these immortalized cells showed anchorage-independent growth as they formed colonies in soft agar and grew above the agar layer. Expression of androgen-regulated prostate specific gene NKX3.1 and epithelial specific cytokeratin 8 (CK8) but not prostate specific antigen (PSA) and androgen receptor was detected in RC-58T/hTERT cells. Prostate stem cell antigen (PSCA) and p16 were also expressed in this cell line. RC-58T/hTERT cells showed growth inhibition when exposed to retinoic acid and transforming growth factor (TGF)-β1 known potent inhibitors of prostate epithelial cell growth. A number of chromosome alterations were observed including the loss of chromosomes Y, 3p, 10p, 17p, 18q and the gain of chromosomes 16 and 20. These results demonstrate that this primary tumor-derived HPE cell line retained its transformed phenotypes and should allow studies to elucidate molecular and genetic alterations involved in prostate cancer. This is the first documented case of an established human prostate cancer cell line from a primary tumor of a prostate cancer patient with telomerase.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C, Tanke HJ, Schroder FH, van Dekken H . 2000 Lab. Invest. 80: 931–942

  • Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M . 1992 Cancer Res. 52: 5991–5996

  • Bright RK, Wocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM, Topalian SL . 1997 Cancer Res. 57: 995–1002

  • Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL . 1999 Prostate 38: 303–312

  • Burger AM, Fiebig HH, Kuettel MR, Lautenberger JA, Kung H-F, Rhim JS . 1998 Int. J. Oncol. 13: 1043–1048

  • Dahiya R, McCarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G . 1997 Int. J. Cancer 71: 20–25

  • Dong FT, Isaacs WB, Isaacs JT . 1997 Curr. Opin. Oncol. 9: 101–107

  • Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L, Ostrander EA . 1999 Am. J. Hum. Genet. 64: 776–787

  • Greider CW . 1999 Trends Genet. 15: 109–112

  • Hukku B, Mally M, Cher ML, Peehl DM, Rhim JS . 2000 Cancer Genet. Cytogenet. 120: 117–126

  • Ittmann MM . 1998 Oncol. Reports 5: 1329–1335

  • Iype PT, Iype LE, Verma M, Kaighn ME . 1998 Int. J. Oncol. 12: 257–263

  • Jiang X-R, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C-P . 1999 Nature Genet. 21: 111–114

  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015

  • Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ . 1998 Nature 396: 84–88

  • Landis SH, Murray T, Bolden S, Wingo PA . 1999 CA Cancer J. Clin. 49: 8–31

  • McNicol PJ, Dodd JG . 1990 J. Clin. Microbiol. 28: 409–412

  • Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW . 1999 Nature Genet. 21: 115–118

  • Peehl DM, Wong ST, Bazinet M, Stamey TA . 1989 Growth Factors 1: 237–250

  • Perinchery G, Bukurov N, Nakajima K, Chang J, Li LC, Dahiya R . 1999 Int. J. Cancer 83: 610–614

  • Ratsch SB, Gao Q, Srinivasan S, Wazer DE, Band V . 2001 Radiat. Res. 155: 143–150

  • Rhim JS . 2000 Prostate Cancer and Prostatic Dis. 3: 229–235

  • Sauter G, Bubendorf L, Moch H, Gasser TC, Mihatsch MJ . 1998 Pathologe 19: 63–68

  • Serth J, Panitz F, Paeslack U, Kuczyk A, Jonas U . 1999 Cancer Res. 59: 823–825

  • Sommerfeld H-J, Meeker AK, Piatyszek MA, Bova GS, Shay W, Coffey DS . 1996 Cancer Res. 56: 218–222

  • Steuer AF, Rhim JS, Hentosh PM, Ting RC . 1977 J. Natl. Cancer Inst. 58: 917–921

  • Weijerman PC, Kiong JJ, Wong ST, Niesters HG, Peehl DM . 1994 Cancer Res. 54: 5579–5583

  • Xu LL, Srikantan V, Sesterhenn IA, Augutus M, Dean R, Moul JW, Carter KC, Srivastava S . 2000 J. Urol. 163: 972–979

  • Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar AG, Bronstein A, Chiu C-P, Herron GS . 1999 J. Biol. Chem. 274: 26141–26148

Download references

Acknowledgements

We thank V Band for kindly providing the LXSN-hTERT and B Hukku for performing the GTG-banding.

Author information

Authors and Affiliations

  1. Department of Surgery, Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Bethesda, Maryland, MD 20814, USA

    Yutaka Yasunaga, Keiichiro Nakamura, Daejin Ko, Shiv Srivastava, Judd W Moul & Johng S Rhim

  2. Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC 20307, USA

    Isabell A Sesterhenn

  3. Department of Surgery, Urology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA

    Judd W Moul & David G McLeod

Authors
  1. Yutaka Yasunaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keiichiro Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daejin Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shiv Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Judd W Moul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Isabell A Sesterhenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David G McLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Johng S Rhim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johng S Rhim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasunaga, Y., Nakamura, K., Ko, D. et al. A novel human cancer culture model for the study of prostate cancer. Oncogene 20, 8036–8041 (2001). https://doi.org/10.1038/sj.onc.1205002

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205002

Keywords

This article is cited by

Search

Advanced search

Quick links